LDE225 Cream
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LDE225 Cream, covering 2017-05-05 to 2017-05-05. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) [Phase 2, Phase 3]